OncoCyte Corporation (LON:0KCC)
2.768
+0.003 (0.11%)
At close: Feb 19, 2025
OncoCyte Revenue
OncoCyte had revenue of $115.00K USD in the quarter ending September 30, 2024, a decrease of -73.19%. This brings the company's revenue in the last twelve months to $709.00K, down -51.54% year-over-year. In the year 2023, OncoCyte had annual revenue of $1.50M with 56.89% growth.
Revenue (ttm)
$709.00K
Revenue Growth
-51.54%
P/S Ratio
n/a
Revenue / Employee
$15.41K
Employees
46
Market Cap
44.15M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Genus | 668.80M |
OncoCyte News
- 8 days ago - AWM Investment Company, Inc. Increases Stake in OncoCyte Corp - GuruFocus
- 12 days ago - Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - GlobeNewsWire
- 13 days ago - Oncocyte prices $29.1M equity offering - Seeking Alpha
- 6 weeks ago - Oncocyte names Paul Billings as consulting chief medical officer - Seeking Alpha
- 6 weeks ago - Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer - GlobeNewsWire
- 6 weeks ago - Oncocyte Expands Market Opportunity for VitaGraft™ Kidney - GlobeNewsWire
- 2 months ago - Oncocyte to Participate in "J.P. Morgan Week" and Host Investor Meetings - Benzinga
- 3 months ago - OncoCyte Corporation (OCX) Q3 2024 Earnings Call Transcript - Seeking Alpha